Exheus — Seed (estimated) · €650K

Exheus is an RNA-analysis and genomic data science spin-off of Hospital de Sant Pau and UPC. It closed a €900K capital increase to expand into Europe and build a B2B digital platform for healthcare professionals. About €650K came from investors including more than 100 business angels through Capital Cell, and €250K came from a CDTI financing line; EIT Health added a separate €50K grant.